DRREDDYBSEDr Reddys Laboratories LtdMediumNeutral
Announced Tue, 12 May · 17:08 IST

Appointment of M/s Deloitte Haskins & Sells, LLP, Chartered Accountants as Statutory Auditors

Auditor Resigned MidtermManagement Changes View source PDF

DRREDDY · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close
+2.7%1-day move
₹1267.50
prior close
₹1245.60
base price
After-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
+1.0+1.5+1.7+2.1+2.7+6.0+5.0+5.2+4.2+3.4+0.1+0.9-2.4
Up moveDown movePending
AI summary

Dr. Reddy's Laboratories Board meeting on May 12, 2026 approved multiple governance changes: (1) Re-appointed Dr. K P Krishnan as Independent Director for a second 5-year term starting January 2027; (2) Appointed Mr. Srikanth Velamakanni, Co-Founder and CEO of Fractal (India's first listed pure-play AI company), as Independent Director for 5 years from July 2026; (3) Appointed Deloitte Haskins & Sells LLP as Statutory Auditors for a 5-year term from the 42nd to 47th AGM, replacing the previous auditor; (4) Re-appointed Sagar & Associates as Cost Auditors for FY 2026-27; (5) Elevated Mr. Sandeep Khandelwal, Global Generics India Head (who grew the India business from Rs 2,300 crore to Rs 7,000 crore in 7 years) as Senior Management Personnel and Management Council member. All appointments are subject to shareholder approval at the ensuing AGM.

Likely market impact

The appointment of Deloitte, a Big 4 firm, as statutory auditor indicates a potential change in the previous auditor relationship. The addition of Srikanth Velamakanni, a prominent AI and technology leader, strengthens board expertise in technology and digital transformation. The elevation of Sandeep Khandelwal underscores the company's strong India business performance. Overall, these are positive governance and leadership signals for shareholders.